![]() Sanofi Genzyme Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. | ![]() Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics. | ![]() Amicus Therapeutics Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases. | |
Founding Date | Founding Date 1981 | Founding Date 1980 | Founding Date 2002 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Cambridge, US HQ Macquarie Park, AU Malaga, AU Virginia, AU São Paulo, BR Mississauga, CA Toronto, CA see more | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Sydney, AU Wien, AT Diegem, BE Santo Amaro, BR see more | Locations Philadelphia, US HQ Northbridge, AU Pointe Claire, CA Paris, FR München, DE Dublin, IE Milano, IT see more |
Employees | Employees 9,9041% decrease | Employees 25,200 | Employees 58415% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 170.4 b | Valuation ($) 3.4 b |
Financial | |||
Revenue (est.) | Revenue (est.) €10.4b (FY, 2019) | Revenue (est.) $36.8b (FY, 2025) | Revenue (est.) $634.2m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $12b (FY, 2025) | Cost of goods $72.9m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $24.7b (FY, 2025) | Gross profit $561.3m (FY, 2025) |
Net income | Net income N/A | Net income $7.7b (FY, 2025) | Net income ($27.1m) (FY, 2025) |
Operating ⚠ | |||
Countries | Countries 100 (Nov, 2020) | Countries 100 (FY, 2020) | Countries N/A |
Patents (US) | Patents (US) 605 (Nov, 2020) | Patents (US) 31 (FY, 2020) | Patents (US) N/A |

Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
View company
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
View company